Literature DB >> 33470542

Noble Metal Nanomaterials for NIR-Triggered Photothermal Therapy in Cancer.

Zhuoqian Lv1, Sijia He2, Youfu Wang1, Xinyuan Zhu1.   

Abstract

It is of great significance to develop anticancer therapeutic agents or technologies with high degree of specificity and patient compliance, while low toxicity. The emerging photothermal therapy (PTT) has become a new and powerful therapeutic technology due to its noninvasiveness, high specificity, low side effects to normal tissues and strong anticancer efficacy. Noble metal nanomaterials possess strong surface plasmon resonance (SPR) effect and synthetic tunability, which make them facile and effective PTT agents with superior optical and photothermal characteristics, such as high absorption cross-section, incomparable optical-thermal conversion efficiency in the near infrared (NIR) region, as well as the potential of bioimaging. By incorporating with various functional reagents such as antibodies, peptides, biocompatible polymers, chemo-drug and immune factors, noble metal nanomaterials have presented strong potential in multifunctional cancer therapy. Herein, the recent development regarding the application of noble metal nanomaterials for NIR-triggered PTT in cancer treatment is summarized. A variety of studies with good therapeutic effects against cancer from impressive photothermal efficacy of noble metal nanomaterials are concluded. Intelligent nanoplatforms through ingenious fabrication showing potential of multifunctional PTT, combined with chemo-therapy, immunotherapy, photodynamic therapy (PDT), as well as simultaneous imaging modality are also demonstrated.
© 2021 Wiley-VCH GmbH.

Entities:  

Keywords:  cancer therapy; light penetration; noble metal nanomaterials; photothermal therapy; surface plasmon resonance

Mesh:

Substances:

Year:  2021        PMID: 33470542     DOI: 10.1002/adhm.202001806

Source DB:  PubMed          Journal:  Adv Healthc Mater        ISSN: 2192-2640            Impact factor:   9.933


  8 in total

Review 1.  Manganese-based hollow nanoplatforms for MR imaging-guided cancer therapies.

Authors:  Shuang Liang; Guangfu Liao; Wenzhen Zhu; Li Zhang
Journal:  Biomater Res       Date:  2022-07-06

Review 2.  Cutting-Edge Progress in Stimuli-Responsive Bioadhesives: From Synthesis to Clinical Applications.

Authors:  Elham Khadem; Mahshid Kharaziha; Hamid Reza Bakhsheshi-Rad; Oisik Das; Filippo Berto
Journal:  Polymers (Basel)       Date:  2022-04-22       Impact factor: 4.967

Review 3.  Multi-target tyrosine kinase inhibitor nanoparticle delivery systems for cancer therapy.

Authors:  Wenjing Xu; Chunping Ye; Xin Qing; Shengli Liu; Xinyi Lv; Wenjun Wang; Xiaochen Dong; Yewei Zhang
Journal:  Mater Today Bio       Date:  2022-07-12

4.  A highly efficient polydopamine encapsulated clinical ICG theranostic nanoplatform for enhanced photothermal therapy of cervical cancer.

Authors:  Zhong Du; Rong Ma; Shuang Chen; Huimin Fan; Youqiang Heng; Ting Yan; Gulinigaer Alimu; Lijun Zhu; Xueliang Zhang; Nuernisha Alifu; Cailing Ma
Journal:  Nanoscale Adv       Date:  2022-08-11

Review 5.  Research Progress of Photothermal Nanomaterials in Multimodal Tumor Therapy.

Authors:  Xiaolu Shi; Ye Tian; Yang Liu; Zhengrong Xiong; Shaobo Zhai; Shunli Chu; Fengxiang Gao
Journal:  Front Oncol       Date:  2022-07-06       Impact factor: 5.738

Review 6.  Nanodrugs alleviate acute kidney injury: Manipulate RONS at kidney.

Authors:  Qiaohui Chen; Yayun Nan; Yuqi Yang; Zuoxiu Xiao; Min Liu; Jia Huang; Yuting Xiang; Xingyu Long; Tianjiao Zhao; Xiaoyuan Wang; Qiong Huang; Kelong Ai
Journal:  Bioact Mater       Date:  2022-09-29

7.  K. ZHENG ET AL.Gold-nanoparticle-based multistage drug delivery system for antitumor therapy.

Authors:  Kaikai Zheng; Dong Zhou; Lili Wu; Jian Li; Bing Zhao; Shihao Zhang; Ruiying He; Lan Xiao; Iqbal Zoya; Li Yu; Yuhong Zhang; Yulin Li; Jie Gao; Kaichun Li
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

8.  Synthesis of dual-stimuli responsive metal organic framework-coated iridium oxide nanocomposite functionalized with tumor targeting albumin-folate for synergistic photodynamic/photothermal cancer therapy.

Authors:  Xiangtian Deng; Renliang Zhao; Qingcheng Song; Yiran Zhang; Haiyue Zhao; Hongzhi Hu; Zhen Zhang; Weijian Liu; Wei Lin; Guanglin Wang
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.